leadf
logo-loader
viewNovavax, Inc.

Novavax to start late-stage trials for COVID-19 vaccine in UK

The US firm will enrol up to 10,000 participants aged 18-84 over the next six weeks

Novavax, Inc. - Novavax to start late-stage trials for COVID-19 vaccine in UK

Novavax Inc (NASDAQ:NVAX) is set to start late-stage trials for its COVID-19 vaccine candidate in the UK.

The US firm will enrol up to 10,000 participants aged 18-84 over the next six weeks, with half receiving the formulation and half receiving a placebo.

At least a quarter will be aged 65 and above while there will be a focus on groups most affected by the pandemic such as ethnic minorities.

Up to 400 volunteers will receive both Novavax’s candidate and a seasonal flu vaccine to see if the combination works.

Data for from the Phase II of clinical trials are expected in the fourth quarter of 2020.

It is the fourth pharma company entering the final stage of tests for a COVID-19 jab, following AstraZeneca, Pfizer and Moderna.

The UK struck a deal with Novavax last month to provide support and infrastructure as well as securing 60mln doses if the vaccine is approved.

On Thursday, Westminster announced a new round of funding to the NHS and public services the support needed to respond to coronavirus, with £24.3bn pledged since the Summer Economic Update in July.

Quick facts: Novavax, Inc.

Price: 80.71 USD

NASDAQ:NVAX
Market: NASDAQ
Market Cap: $4.95 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Purepoint Uranium Group sees great opportunity as they look to develop in...

Purepoint Uranium Group (CVE: PTU) President and CEO Chris Frostad joined Steve Darling from Proactive to shared details about the company that is focused on the exploration of its projects in the Canadian Athabasca Basin, the world’s richest uranium region. Frostad telling Proactive about...

9 hours, 50 minutes ago

2 min read